Vitalhub Corp. (TSE:VHI – Get Free Report) has been given an average rating of “Buy” by the six brokerages that are currently covering the company, Marketbeat.com reports. Five equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is C$12.67.
Separately, National Bank Financial reduced their price target on Vitalhub from C$14.00 to C$11.00 and set an “outperform” rating for the company in a report on Wednesday, May 27th.
Read Our Latest Stock Report on Vitalhub
Vitalhub Stock Performance
Vitalhub (TSE:VHI – Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported C$0.03 earnings per share (EPS) for the quarter. Vitalhub had a net margin of 5.89% and a return on equity of 2.79%. The business had revenue of C$31.74 million for the quarter. Equities research analysts forecast that Vitalhub will post 0.2296467 EPS for the current year.
About Vitalhub
VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.
Featured Stories
- Five stocks we like better than Vitalhub
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.
